(Q52046091)

20 April 2018

title

COMPARE: a web accessible tool for investigating mechanisms of cell growth inhibition. (English)

1 reference

20 April 2018

author name string

Daniel W Zaharevitz

1

1 reference

20 April 2018

Susan L Holbeck

2

1 reference

20 April 2018

Christopher Bowerman

3

1 reference

20 April 2018

Penny A Svetlik

4

1 reference

20 April 2018

publication date

1 January 2002

1 reference

20 April 2018

Journal of Molecular Graphics & Modelling

published in

1 reference

20 April 2018

volume

20

1 reference

20 April 2018

page(s)

297-303

1 reference

20 April 2018

issue

4

1 reference

20 April 2018

New colorimetric cytotoxicity assay for anticancer-drug screening

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

A gene expression database for the molecular pharmacology of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

Systematic variation in gene expression patterns in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

A synthetic inhibitor of the mitogen-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agent.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

Azatoxin derivatives with potent and selective action on topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

Cytotoxicity and characterization of an active metabolite of benzamide riboside, a novel inhibitor of IMP dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

Site of action of two novel pyrimidine biosynthesis inhibitors accurately predicted by the compare program.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

Identification of a novel inhibitor (NSC 665564) of dihydroorotate dehydrogenase with a potency equivalent to brequinar.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

Protein-linked DNA strand breaks induced by NSC 314622, a novel noncamptothecin topoisomerase I poison.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900126-7

7 January 2021

10.1016/S1093-3263(01)00126-7

Identifiers

DOI

1 reference

20 April 2018

PubMed ID

11858638

1 reference

20 April 2018